top of page
Executive Spotlights

Roche Expands Point of Care Diagnostics Portfolio with $295M Acquisition of LumiraDx's Point of Care Diagnostics Platform

Basel, December 29, 2023 (Reuters) -- The Swiss pharmaceutical company, announced its agreement to acquire LumiraDx's (LMDX.O) Point of Care diagnostics platform business which offers a variety of immunoassay and clinical chemistry tests on a single platform, for approximately $295 million. The completion of the transaction is anticipated by mid-2024, at which point the acquired business segment will be integrated into Roche's diagnostics unit, as stated by the pharmaceutical company.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page